10th Neurology Update Seminar – Berlin
Langenbeck-Virchow-Haus-Veranstaltungs GmbHBerlin, SPAIN Visit the Venue to read more
Lively lectures, cutting-edge studies and more than 1,000 participants contributed to the great success of Neuro Update 2017. We would like to thank our speakers, all participants and our partners for the great commitment and the many lively discussions!
The preparations for our anniversary event are already in full swing. This will take place on 2 and 3 March 2018 in Mainz and on 16 and 17 March 2018 in Berlin. We sincerely invite you to this!
The two-day participation in Neuro Update 2018 brings you back to the latest state of knowledge. Our team of experts speaks about all relevant topics - compact, up-to-date and practical! For this purpose, the speakers screen all publications of the respective subareas within the current research year, select the most important studies and present them - with special consideration of practical relevance - on the update.
As a participant, you will receive the comprehensive manual NEUROLOGIE 2018, also as a practical eBook as well as the lectures of the speakers in electronic format. So you have an extensive reference book available after the event!
We look forward to welcoming you to the Neuro Update 2018!
Prof. Dr. Gerhard Hamann
Direktor der Neurologischen Klinik
Prof. Dr. Marianne Dieterich
Direktorin der Klinik für Neurologie
Klinikum Großhadern, Ludwig-Maximilians-Universität München
Prof. Dr. Volker Limmroth
Chefarzt der Klinik für Neurologie und Palliativmedizin
Klinikum Köln-Merheim, Kliniken der Stadt Köln
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
The following hotels will be open from 01.03. until 03.03.2018 a room contingent. There you can book your room under the keyword "Neuro Update". After the mentioned dates can be reserved only on request and then valid prices. All prices are per night including the currently valid VAT. The distances to the venue are approximate. Hotel offers can also be found at: www.hrs.de
Sanofi Genzyme is Sanofi's specialty care global business focused on rare diseases, multiple sclerosis, cancer and autoimmune diseases. Sanofi Genzyme helps people with severe and complex diseases that are often difficult to diagnose and treat. The commitment is to research and develop groundbreaking therapies that give new hope to patients and their families around the world. The business approach of Sanofi Genzyme is marked by a long tradition of developing highly specialized treatments and intensive collaboration with physicians and patient organizations.
Founded in 1981 under the name of Genzyme in Cambridge, near Boston, USA, the company quickly became a leading global biotechnology company. Since 2011, Genzyme is part of Sanofi. Since 2016, the focus has also been on Sanofi's oncology and immunology developments.
For decades Sanofi Genzyme has not only focused on the development and distribution of its own medicines, but also offers both physicians and patient organizations need-based support, with the aim of improving the lives of affected patients.
Further information about the company can be found at www.sanofigenzyme.de .
Contact No.: +49 611 204809-0,+49 (0) 611 94587990
Email: firstname.lastname@example.org, email@example.com